A Natural IgA-Anti-F(ab′)2γ Autoantibody Occurring in Healthy Individuals and Kidney Graft Recipients Recognizes an IgG1 Hinge Region Epitope

Journal of Immunology

Volumn 157, Issue 9, 1996, Pages 4251-4257

  Terness, Peter ^a   Navolan, Dan ^a   Moroder, Luis ^b   Siedler, Frank ^b   Weyher, Elisabeth ^b   Kohl, Ingrid ^a   Dufter, Christoph ^a   Welschof, Martin ^a   Drugarin, Doina ^c   Schneider, Francisc ^c   Opelz, Gerhard ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^c VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIIDIOTYPIC ANTIBODY; AUTOANTIBODY; EPITOPE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN G; PEPTIDE FRAGMENT; VASOACTIVE INTESTINAL POLYPEPTIDE;

AMINO ACID SEQUENCE; ANTIBODY SPECIFICITY; ARTICLE; BINDING COMPETITION; BLOOD; CHEMISTRY; CIRCULAR DICHROISM; CROSS REACTION; HUMAN; IMMUNOLOGY; KIDNEY TRANSPLANTATION; MOLECULAR GENETICS; PROTEIN CONFORMATION; SYNTHESIS;

AMINO ACID SEQUENCE; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODY SPECIFICITY; AUTOANTIBODIES; BINDING, COMPETITIVE; CIRCULAR DICHROISM; CROSS REACTIONS; EPITOPES; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN FAB FRAGMENTS; IMMUNOGLOBULIN G; KIDNEY TRANSPLANTATION; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROTEIN CONFORMATION; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0030293481     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Bona, C., and P. A. Cazenave. 1981. In vitro suppression of immunoglobulin synthesis by anti-allotype and anti-idiotype antibodies. In Lymphocyte Regulation by Antibodies. C. Bona and P. A. Cazenave, eds. John Wiley & Sons, New York, p. 205.
2. Bona, C., ed. 1987. Modern Concepts in Immunology. Wiley Interscience Publication, New York.
3. Bona, C., K. Siminovitch, M. Zanetti, and A. Theofilopoulos, eds. 1993. The Molecular Pathology of Autoimmune Diseases. Harwood Academic Publishers, Switzerland.
4. Manheimer, A., and C. Bona. 1985. Age-dependent isotype variation during secondary immune response in MLR/lpr mice producing autoanti-γ-globulin antibodies. Eur. J. Immunol. 15:718.
5. Zouali, M., and A. Eyquem. 1983. Idiotypic-anti-idiotypic interactions in systemic lupus erythematosus: demonstration of oscillary levels of anti-DNA autoantibodies and reciprocal anti-idiotypic activity in a single patient. Ann. Immunol. 134C:377.
6. Rossi, F., G. Dietrich, and M. D. Kazatchkine. 1989. Anti-idiotypes against autoantibodies in normal immunoglobulins: evidence for network regulation of human autoimmune responses. Immunol. Rev. 110:135.
7. Suciu-Foca, N., E. Reed, C. Rohowsky, P. Kung, and D. W. King. 1983. Anti-idiotypic antibodies to anti-HLA receptors induced by pregnancy. Proc. Natl. Acad. Sci. USA 80:830.
8. Suciu-Foca, N., E. Reed, V. D. D'Agati, E. Ho, D. J. Cohen, R. McCabe, J. M. Brensilver, D. W. King, and M. Hardy. 1991. Soluble HLA antigens, anti-HLA antibodies, and antiidiotypic antibodies in the circulation of renal transplant recipients. Transplantation 51:593.
9. Suciu-Foca, N., E. Reed, C. Marboe, X. Yu Ping, Y. Sung, E. Rose, K. Reemtsma, and D. W. King. 1991. The role of anti-HLA antibodies in heart transplantation. Transplantation 51:716.
10. Suciu-Foca, N. 1993. Transplantation and autoimmunity. In The Molecular Pathology of Autoimmune Diseases. C. Bona, K. Siminovitch, M. Zanetti, and A. Theofilopoulos, eds. Harwood Academic Publishers, Chur, Switzerland, p. 756.
11. Reed, E., V. Bonagura, P. Kung, D. W. King, and N. Suciu-Foca. 1983. Antiidiotypic antibodies to HLA-DR4 and DR2. J. Immunol. 131:2890.
12. Reed, E., M. Hardy, A. Benvenisty, C. Lattes, J. Brensilver, R. McCabe, K. Reemtsma, D. W. King, and N. Suciu-Foca. 1981. Effect of antiidiotypic antibodies to HLA on graft survival in renal-allograft recipients. N. Engl. J. Med. 316:1450.
13. Chia, D., T. Horimi, P. I. Terasaki, and M. Hermes. 1982. Association of anti-Fab and anti-IgG antibodies with high kidney transplant survival. Transplant. Proc. 14:322.
14. 2 antibodies with higher kidney transplant survival rates. Transplantation 33:603.
15. Feduska, N. J. Jr., D. Chia, P. I. Terasaki, and L. Sugich. 1991. Effect of anti-Fab antibodies on renal allografts. Transplant. Proc. 23:1277.
16. Süsal, C., J. Groth, R. F. Tanzi-Fetta, G. Kirste, C. Doerr, P. Terness, G. May, G. Staehler, and G. Opelz. 1992. Characterization of protective anti-Fab autoantibodies in kidney graft recipients. Transplant. Proc. 24:2523.
17. Lim, E. C., and P. I. Terasaki. 1990. Outcome of kidney transplantation in different diseases. Clin. Transplant. 4:461.
18. 2 antibodies in patients with primary IgA nephropathy. Clin. Exp. Immunol. 77:15.
19. Süsal, C., V. Daniel, C. Dörr, R. Zimmermann, A. Huth-Kühne, and G. Opelz. 1993. IgA-anti-Fab autoantibodies and disease progression in AIDS. Immunol. Lett. 36:27.
20. Süsal, C., H. H. Oberg, V. Daniel, C. Dörr, P. Terness, A. Huth-Kühne, R. Zimmermann, and G. Opelz. 1994. Isotypes and IgG subclasses of anti-Fab antibodies in human immunodeficiency virus-infected hemophilia patients. Vox Sang. 66:37.
21. Süsal, C., H. Maier, K. Lorenz, and G. Opelz. 1994. Association of IgA-anti-Fab autoantibodies with disease stage in head- and neck-cancer. Int. J. Cancer 57:47.
22. Moroder, L., W. Göhring, R. Nyfeler, R. Scharf, P. Thamm, and G. Wendlberger. 1983. Zur Synthese von Human-Little-Gastrin und dessen Leucin-15-, Norleucin-15- und Methoxinin-15-Analoga. Hoppe-Seyler's Z. Physiol. Chem. 364:157.
23. Göhring, W., L. Moroder, G. Borin, A. Lobbia, J. P. Bali, and E. Wünsch. 1984. Synthese von Gastrin-aktiven Peptiden: Untersuchungen zur Struktur-Wirkungsbeziehung des natürlichen Hormons Human-Little-Gastrin-I. Hoppe-Seyler's Z. Physiol. Chem. 365:83.
24. Wünsch, E., L. Moroder, S. Göhring-Romani, H. J. Musiol, W. Göhring, and G. Bovermann. 1988. Synthesis of the bis-cystinyl-fragment 225-232/225′-232′ of the human IgG1 hinge region. Int. J. Pept. Protein Res. 32:368.
25. Wünsch, E., L. Moroder, G. Hübener, H. J. Musiol, R. von Grünigen, W. Göhring, R. Scharf, and C. H. Schneider. 1991. Fully synthetic immunogens. III. Synthesis of hinge peptide/gastrin conjugates and their immunological properties. Int. J. Pept. Protein Res. 37:90.
26. Wünsch, E., L. Moroder, S. Göhring-Romani, H. J. Musiol, W. Göhring, and R. Scharf. 1991. Fully synthetic immunogens. Part II. Studies on parallel dimerization of the human IgG1 hinge fragment 225-232 with N- and C-terminal gastrin-related extensions. Int. J. Pept. Protein Res. 37:61.
27. Wünsch, E., and G. Wendlberger. 1986. Vasoactive intestinal polypeptide (VIP): synthese von biologisch aktivem 17-Norleucine-Analogon. Wien Tieraerztl. Monatsschr. 73:164.
28. Musiol, H.-J., F. Siedler, D. Quarzago, and L. Moroder. 1994. Redox-active bis-cysteinyl-peptides. I. Synthesis of cyclic cystinyl-peptides by conventional methods in solution and on solid supports. Biopolymers 34:1553.
29. 2 antibody recognizes a conformational IgG1 hinge epitope. J. Immunol. 154:6446.
30. Marquart, M., J. Deisenhofer, R. Huber, and W. Palm. 1980. Crystallographic refinement and atomic models of the intact immunoglobulin molecule Kol and its antigen-binding fragment at 3.0Å and 1.9Å resolution. J. Mol. Biol. 141:369.
31. Moroder, L., J. P. Bali, and Y. Kobayashi. 1991. Synthetic immunogens. Part IV. Conformational studies on gastrin conjugates with the human immunoglobulin G1 hinge peptide. Biopolymers 31:595.
32. Kessler, H., S. Mronga, G. Müller, L. Moroder, and R. Huber. 1991. Conformational analysis of an IgG1 hinge peptide derivative in solution determined by NMR spectroscopy and refined by restrained molecular dynamics simulation. Biopolymers 31:1189.
33. Moroder, L., H. J. Musiol, K. Köcher, J. P. Bali, C.-H. Schneider, W. Guba, G. Müller, D. F. Mierke, and H. Kessler. 1993. Synthetic immunogens: the effect of the conformational space on biological and immunological responses to dimeric hormone constructs. Eur. J. Biochem. 212:325.
34. Waterhous, D. V., and W. C. Johnson, Jr. 1994. Importance of environment in determining secondary structure in proteins. Biochemistry 33:2121.
35. Quarzago, D., and L. Moroder. 1994. Conformational analysis of bioactive peptides in reverse micelles as mimics of cell membrane environments. Lett. Pept. Sci. 1:171.
36. 1H-NMR spectroscopy. Biopolymers 31:459.
37. Lau, S. Y. M., A. K. Taneja, and R. S. Hodges. 1984. Synthesis of a model protein of defined secondary and quaternary structure. J. Biol. Chem. 259:13253.
38. Nisonoff, A., J. E. Hopper, and S. B. Spring. 1975. The Antibody Molecule. Academic Press, New York.
39. Woody, R. W. 1985. Circular dichroism of peptides. In The Peptides: Analysis, Synthesis, Biology, Vol. 7. S. Udenfriend and J. Meienhofer, eds. Academic Press, Orlando, p. 16.
40. Lund, J., G. Winter, P. T. Jones, J. D. Pound, T. Tanaka, M. R. Walker, P. J. Artymiuk, Y. Arata, D. R. Burton, R. Jefferis, and J. M. Woof. 1991. Human FcγRI and FcγRII interact with distinct but overlapping sites on human IgG. J. Immunol. 147:2657.
41. H2 domain of IgG for mouse FcγRII. Mol. Immunol. 29:53.
42. Brekke, O. H., T. E. Michaelsen, and I. Sandlie. 1995. The structural requirement for complement activation by IgG: does it hinge on the hinge? Immunol. Today 16:85.